Eli Lilly’s news that it plans to cut insulin costs for patients will help, not hinder, the recent efforts in California and by entrepreneurs such as Mark Cuban to offer lower-cost alternatives, drug pricing experts said.
Category: Diabetes
Empowering Type 2 diabetes patients with innovative insulin management tools [PODCAST]
Subscribe to The Podcast by KevinMD. Catch up on old episodes! Our guest today is James Malone, an endocrinologist and health care executive with over 30 years of experience in the field of diabetes. James has seen firsthand the challenges that many pe…
Armed With Hashtags, These Activists Made Insulin Prices a Presidential Talking Point
Twitter has been a hotbed for the burgeoning insulin access movement and activism surrounding other medical conditions. For people with diabetes, the platform has helped propel concern about insulin prices into policy. Can it continue to win with hashtags?
A doctor’s journey: Navigating chronic disease and empowerment through life coaching
On January 2020, I got the dreaded call: You have Type 1 diabetes. The rest is a blur. I went into a global pandemic, one of the highest risk categories, a red lab value that stared at me “HgbA1c > 15.” As a family physician, I was sup…
California Attorney General Sues Drugmakers Over Inflated Insulin Prices
California Attorney General Rob Bonta is taking three major drugmakers and three distributors to court, alleging the companies illegally raised prices at the expense of diabetes patients.
A Retiree Returns to Work After a Calamitous Year of Health Emergencies
In 2020, diabetes and covid-19 landed David Zipprich in the hospital three times. Even with insurance, he was inundated with bills, debt notices, and calls from collectors.
A personal mission to get obese patients on GLP-1 agonists [PODCAST]
Subscribe to The Podcast by KevinMD. Catch up on old episodes! “Obesity is not the consequence of bad behaviors it is a disease that finally has effective, safe, lasting treatments. Patients with obesity have been marginalized long enough. We, es…
Lack of innovation is leading to disparities in diabetes care
Having spent over 30 years of my career in diabetes, first as a practicing diabetologist and later as a diabetes researcher, I’ve met many people with diabetes. And while diabetes care has evolved significantly over my career, I’m amazed to…
Don’t blame Big Pharma for insulin’s problems
For diabetics, insulin matters as much as H2O. Unfortunately, insulin’s a hell of a lot more expensive than bottled water. High insulin prices force approximately nine million Americans to balance their wallet and well-being. The American Action …
Watch: The Politics of Health Care in California
KHN senior correspondent Angela Hart discussed the most pressing health care issues in California with the nonpartisan group Democracy Winters in mid-November, touching on a variety of issues, from the state’s effort to transform its Medicaid program to its plan to produce generic insulin.
